Cyanoacrylate adhesive provides efficient local drug delivery

Clinical Orthopaedics and Related Research

Volumn 451, Issue , 2006, Pages 242-250

  Eskandari, Metin Manouchehr ^a,b   Ozturk, Ozlem Goruroglu ^a   Eskandari, Hatice Gulcin ^a   Balli, Ebru ^a   Yilmaz, Cengiz ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENBUCRILATE; GELATIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG CARRIER; GELATIN SPONGE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; FLUORESCENCE POLARIZATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; IMMUNOASSAY; IN VITRO STUDY; IN VIVO CULTURE; INFLAMMATORY DISEASE; LEUKOCYTE COUNT; MOUSE; MUSCULOSKELETAL DISEASE; NONHUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE; ANIMAL; BIODEGRADABLE IMPLANT; DOSE RESPONSE; DRUG EFFECT; PATHOLOGY; SKELETAL MUSCLE;

ABSORBABLE IMPLANTS; ANIMALS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ENBUCRILATE; GELATIN SPONGE, ABSORBABLE; MICE; MUSCLE, SKELETAL; VANCOMYCIN;

EID: 33749430446     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000224055.24743.c8     Document Type: Article

References (42)

1. Alpaslan C, Alpaslan GH, Oygur T. Tissue reaction to three subcutaneously implanted local hemostatic agents. Br J Oral Maxillofac Surg. 1997;35:129-132.
2. Amarante MT, Constantinescu MA, O'Connor D, Yaremchuk MJ. Cyanoacrylate fixation of the craniofacial skeleton: an experimental study. Plast Reconstr Surg. 1995;95:639-646.
3. Ambrose CG, Clyburn TA, Louden K, Joseph J, Wright J, Gulati P, Gogola GR, Mikos AG. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clin Orthop Relat Res. 2004;421:293-299.
4. Ambrose CG, Gogola GR, Clyburn TA, Raymond AK, Peng AS, Mikos AG. Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin Orthop Relat Res. 2003;415:279-285.
5. Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ. Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orthop Res. 2004;22:703-708.
6. Beardmore AA, Brooks DE, Wenke JC, Thomas DB. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Am. 2005;87:107-112.
7. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J. Antibiotic-loaded plaster of Paris iimplants coated with poly lactide-coglycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop. 1997;21:403-408.
8. Bjorling DE, Jerde TJ, Zine MJ, Busser BW, Saban MR, Saban R. Mast cells mediate the severity of experimental cystitis in mice. J Urol. 1999;162:231-236.
9. Bonutti PM, Weiker GG, Andrish JT. Isobutyl cyanoacrylate as a soft tissue adhesive, an in vitro study in the rabbit Achilles tendon. Clin Orthop Relat Res. 1988;229:241-248.
10. Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic iimplants for internal fixation: a review. Biomaterials. 2000;21:2615-2621.
11. Buranapanitkit B, Srinilta V, Ingviga N, Oungbho K, Geater A, Ovatlarnporn C. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin Orthop Relat Res. 2004;424:244-252.
12. Cayan S, Coşkun B, Bozlu M, Acar D, Akbay E, Ulusoy E. Botulinum toxin type A may improve bladder function in a rat chemical cystitis model. Urol Res. 2003;30:399-404.
13. Cheski PJ, Matthews TW. Endoscopic reduction and internal cyanoacrylate fixation of the zygoma. J Otolaryngol. 1997;26:75-79.
14. Cleveland KB. General principles of infection. In: Canale ST, ed. Campbell's Operative Orthopaedics. Philadelphia, PA: Mosby; 2003:643-659.
15. Dabov G. Osteomyelitis. In: Canale ST, ed. Campbell's Operative Orthopaedics. Philadelphia, PA: Mosby; 2003:661-683.
16. Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong). 2002;10:53-60.
17. Gursel I, Korkusuz F, Turesin F, Alaeddinoglu NG, Hasirci V. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials. 2001;22:73-80.
18. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials. 2005;26:5251-5258.
19. Josse S, Faucheux C, Soueidan A, Grimandi G, Massiot D, Alonso B, Janvier P, Laib S, Pilet P, Gauthier O, Daculsi G, Guicheux JJ, Bujoli B, Bouler JM. Novel biomaterials for bisphosphonate delivery. Biomaterials. 2005;26:2073-2080.
20. Keskin DS, Tezcaner A, Korkusuz P, Korkusuz F, Hasirci V. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair. Biomaterials. 2005;26:4023-4034.
21. Kokubo S, Fujimoto R, Yokota S, Fukushima S, Nozaki K, Takahashi K, Miyata K. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials. 2003;24:1643-1651.
22. Kwasny O, Bockhorn G, Vecsei V. The use of gentamicin collagen floss in the treatment of infections in trauma surgery. Orthopedics. 1994;17:421-425.
23. Lazarettos J, Efstathopoulos N, Papagelopoulos PJ, Savvidou OD, Kanellakopoulou K, Giamarellou H, Giamarellos-Bourboulis EJ, Nikolaou V, Kapranou A, Papalois A, Papachristou G. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis. Clin Orthop Relat Res. 2004;423:253-258.
24. Littlewood-Evans AJ, Hattenberger MR, Luscher C, Pataki A, Zak O, O'Reilly T. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun. 1997;65:3438-3443.
25. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, Raschke M. Gentamicin coating of metallic iimplants reduces implant-related osteomyelitis in rats. Bone. 2003;32:521-531.
26. Magnan PE, Seyral P, Raoult D, Branchereau A. In vitro antistaphylococcal activity of collagen-sealed Dacron vascular prostheses bonded with rifampin, vancomycin, or amikacin. Ann Vasc Surg. 1994;8:243-247.
27. Mader JT. Animal models of osteomyelitis. Am J Med. 1985;78:213-217.
28. Mader JT, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrob Agents Chemother. 1997;41:415-418.
29. Makinen TJ, Veiranto M, Knuuti J, Jalava J, Tormala P, Aro HT. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Bone. 2005;36:292-299.
30. Miyazaki S, Takahashi A, Kubo W, Bachynsky J, Loebenberg R. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharm Sci. 2003;6:238-245.
31. Monzon M, Garcia-Alvarez F, Lacleriga A, Amorena B. Evaluation of four experimental osteomyelitis infection models by using precolonized implants and bacterial suspensions. Acta Orthop Scand. 2002;73:11-19.
32. Murray BE, Nannini EC. Glycopeptides (vancomycin and teicoplanin), streptogramins (qinupristin-dalfopristin), and lipopeptides (daptomycin). In: Mandell Gl, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:417-734.
33. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis. 1988;10:103-110.
34. Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55:1679-1698.
35. Seligson D, Klemm K. Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft. Clin Orthop Relat Res. 1999;360: 30-36.
36. Shermak MA, Wong L, Inoue N, Crain BJ, Im MJ, Chao EY, Manson PN. Fixation of the craniofacial skeleton with butyl-2-cyanoacrylate and its effects on histotoxicity and healing. Plast Reconstr Surg. 1998;102:309-318.
37. Stolle LB, Arpi M, Jorgensen PH, Riegels-Nielsen P, Keller J. In situ gentamicin concentrations in cortical bone: an experimental study using microdialysis in bone. Acta Orthop Scand. 2003;74:611-616.
38. Trott AT. Cyanoacrylate tissue adhesives: an advance in wound care. JAMA. 1997;277:1559-1560.
39. Ueng SW, Lee SS, Lin SS, Chan EC, Hsu BR, Chen KT. Biodegradable alginate antibiotic beads. Clin Orthop Relat Res. 2000;380: 250-259.
40. Ueng SW, Yuan LJ, Lee N, Lin SS, Chan EC, Weng JH. In vivo study of biodegradable alginate antibiotic beads in rabbits. J Orthop Res. 2004;22:592-599.
41. Wernet E, Ekkernkamp A, Jellestad H, Muhr G. Antibiotic-containing collagen sponge in therapy of osteitis. Unfallchirurg. 1992;95:259-264.
42. Wichelhaus TA, Dingeldein E, Rauschmann M, Kluge S, Dieterich R, Schafer V, Brade V. Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. J Antimicrob Chemother. 2001;48:117-119.